PURPOSE: To explore cataract surgeons' real-world experience with an intraocular lens (IOL), enVista ASPIRE™ (EA) and/or enVista ASPIRE™ toric (ETA), including healthcare provider (HCP) satisfaction and IOL utilization patterns.

METHODS: This retrospective, cross-sectional, multicenter study included US cataract surgeons with ≥3 years' experience conducting cataract surgery with monofocal and/or toric IOLs, including EA/ETA IOL implantation on ≥5 patients. Participants completed a retrospective user-experience survey about their initial experience with EA and/or ETA. The study protocol received exemption from a central institutional review board. Survey outcomes included baseline characteristics, patient outcomes, and HCP satisfaction with EA and ETA. A standardized case report form was used to collect clinical and adverse outcomes. This abstract presents the findings from the retrospective user-experience survey.

RESULTS: Survey responses from 6 HCPs were included in the analysis. They performed a mean±SE of 1950±585 cataract surgeries a year, and had previously implanted a mean±SE total of 84±35 EA and 38±18 ETA IOLs. Of the patients treated in the last year, the most commonly implanted IOL (mean±SE, 37.8±10.6%) was full range of vision. Toric IOLs were used in a mean±SE 42.5±12.6% of cases. On a scale of 0 (very dissatisfied) to 10 (very satisfied), 83% and 100% of surgeons rated their satisfaction with the overall performance of the EA and ETA IOL, respectively, as ≥9. Similar ratings were obtained for individual lens qualities and outcomes (e.g., centration, rate of visual disturbances, visual outcomes).

CONCLUSION: This retrospective multicenter study provides important insights into real-world IOL utilization patterns. HCPs reported high satisfaction overall and across key lens qualities and outcomes with EA and ETA IOLs.